About Win-Medicare Private Limited
Data last updated:
Win-Medicare Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Modi-Mundipharma Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL1981PTC011647. Its GSTIN is 07AAACW0631J1ZI (Delhi). The company holds 30 GST registrations, of which 23 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹96.88 Lakh. It was formerly known as Win-Medicare Limited. It is led by directors including Kumkum Modi (Managing Director) and Abhishek Modi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1311 Modi Tower 98 Nehru Place, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,012.12 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹11.63 Cr (net margin 1.1%) and EBITDA of ₹70.05 Cr (EBITDA margin 6.9%).
As per MCA filings, the company has open charges of ₹214.83 Cr and satisfied charges of ₹115.7 Cr on record. Court records list 228 cases involving the company, including 157 filed by the company and 69 filed against it; 53 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in September 2011. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Medley Pharmaceuticals Limited with revenue of ₹1,114.92 Cr. The company has 4 MSME Form 1 returns on record between 2020 and 2021, listing 84 overdue payments to 30 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website umeshmodigroup.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1311 Modi Tower 98 Nehru Place, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Win-Medicare Private Limited
The main business activities of Win-Medicare are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Win-Medicare Private Limited FY 2025 filings available
Win-Medicare Private Limited reported revenue of ₹1,012.12 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Win-Medicare Private Limited
Revenue rose 7% in the latest year. EBITDA rose 12% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Win-Medicare Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹70.05 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.63 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Win-Medicare Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Win-Medicare are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Win-Medicare Private Limited
Win-Medicare Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medley Pharmaceuticals Limited | ₹1,114.92 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Troikaa Pharmaceuticals Limited | ₹1,088.44 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Ahmedabad, Gujarat, India |
| Tenshi Pharmaceuticals Private Limited | ₹1,071.06 Cr (FY 2024) | •••• | •••• | 98.0% | •••• | Bangalore, Karnataka, India |
| Boehringer Ingelheim India Private Limited | ₹1,049.1 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Blue Cross Laboratories Private Limited | ₹1,021.41 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Win-Medicare Private Limited this company | ₹1,012.12 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Umedica Laboratories Private Limited | ₹993.72 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Pardi, Gujarat, India |
| Franco-Indian Pharmaceuticals Private Limited | ₹988.53 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Meyer Organics Private Limited | ₹984.18 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Thane, Maharashtra, India |
| Biocon Pharma Limited | ₹982.5 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Bangalore, Karnataka, India |
| Orchid Pharma Limited Listed | ₹949.4 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Chengalpattu, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Win-Medicare by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Win-Medicare Private Limited
Win-Medicare Private Limited is audited by SARAT JAIN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SARAT JAIN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Win-Medicare Private Limited
Win-Medicare has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Modi Also directs: Sbec Sugar Limited, Bihar Sponge Iron Limited, Modi Illva India Private Limited and 5 more | Director | 11 Mar 1994 | 32 Years 7 Months | Current |
| Kumkum Modi | Managing Director | 01 Apr 1995 | 31 Years 6 Months | Current |
| Bal Krishna Agarwal | Director | 08 May 1981 | 45 Years 5 Months | Current |
| Umesh Kumar Modi | Director | 21 Mar 1990 | 36 Years 6 Months | Current |
| Himani Modi Agarwal Also directs: Modi-Beaphar Private Limited, Modi-Mundipharma Healthcare Private Limited, Modiline Travel Service Private Limited and 5 more | Director | 27 May 1992 | 34 Years 4 Months | Current |
| Jayesh Modi | Director | 17 Nov 2009 | 16 Years 10 Months | Current |
Ownership and Shareholding of Win-Medicare Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Win-Medicare Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2025 | Others | ₹53 Cr | Open |
| 22 Feb 2022 | Others | ₹5 Cr | Open |
| 12 Mar 2021 | Hdfc Bank Limited | ₹14.11 Cr | Open |
| 19 Jun 2015 | Hdfc Bank Limited | ₹7.6 Cr | Open |
| 10 Feb 2014 | Others | ₹135.12 Cr | Open |
Total charge records: 14 View all charges
Deals & Funding of Win-Medicare Private Limited
Win-Medicare Private Limited has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in September 2011.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2010 | Acquisition | ₹29.81 Cr | Buyer: Modi-Mundipharma Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: Modi-Mundipharma Private Limited , an individual Seller: 4 individuals |
| Mar 2006 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Win-Medicare Private Limited
Win-Medicare Private Limited has 228 court cases on record: 157 filed by Win-Medicare, 69 filed against it, 2 where it is another party. 53 cases are pending and 175 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 166 | 46 | 39 |
| High courts | 53 | 17 | 9 |
| Supreme Court | 4 | 2 | 0 |
| NCLAT | 4 | 4 | 4 |
| NCLT | 1 | 0 | 1 |
Cases on record (5 of 228)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Aneta Pharmaceuticals Private Limited | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Bza Medical Private Limited | Pending |
| District court, South East, Delhi | Commercial suit | Filed by the company against The New India Assurance Company Limited | Pending |
| NCLAT, New Delhi | Court case (Competition Appeal(AT)) | Filed against the company by Intas Pharmaceuticals Limited and 3 others | Pending |
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Sai Vasundhara Medicals Private Limited | Disposed |
Full case history
All 228 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Win-Medicare Private Limited
Win-Medicare Private Limited has 4 MSME Form 1 returns on record between 2020 and 2021, listing 84 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 30)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| H.M. Graphics Private Limited | •••• | •••• | •••• |
| Lettershop India Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Era Packaging | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 4 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Win-Medicare Private Limited
Employment history and EPFO contributions of people linked to Win-Medicare.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Win-Medicare Private Limited
Recent Activity on Win-Medicare Private Limited
Win-Medicare Private Limited has 13 board changes on record since 1981: 7 appointments and 6 cessations. The latest: Ritu Aswal was appointed as Nodal Officer on 25 Nov 2019.
29 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Win-Medicare Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Win-Medicare Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Win-Medicare Private Limited
Win-Medicare has 30 GST registrations: 23 active and 7 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW0631J1ZI | Delhi | Active | 01 Jul 2017 |
| 07AAACW0631J2ZH | Delhi | Active | 22 Aug 2017 |
| 03AAACW0631J1ZQ | Punjab | Active | 01 Jul 2017 |
| 04AAACW0631J1ZO | Chandigarh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Win-Medicare Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Win-Medicare Private Limited
Win-Medicare is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 1981 (45+ years old) and is registered under CIN U51397DL1981PTC011647.
Win-Medicare reported revenue of ₹1,012.12 Cr for FY 2025 (up 7% YoY).
Win-Medicare has 6 current directors:
- Kumkum Modi - Managing Director
- Abhishek Modi - Director
- Bal Krishna Agarwal - Director
- Umesh Kumar Modi - Director
- Himani Modi Agarwal - Director
- Jayesh Modi - Director
Win-Medicare reported a net profit of ₹11.63 Cr (net margin 1.1%) and EBITDA of ₹70.05 Cr (EBITDA margin 6.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Win-Medicare is 07AAACW0631J1ZI, registered in Delhi. The company has 30 GST registrations in all, of which 23 are active and 7 are cancelled or inactive. Other active GSTINs include 07AAACW0631J2ZH (Delhi), 03AAACW0631J1ZQ (Punjab), 04AAACW0631J1ZO (Chandigarh).
The CIN (Corporate Identification Number) of Win-Medicare is U51397DL1981PTC011647. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Win-Medicare has 228 court cases on record: 157 filed by the company and 69 filed against it. 53 are pending. Most are in the district courts.
Win-Medicare was incorporated on 28 April 1981, making it 45+ years old. It is registered with the Registrar of Companies, Delhi.
Win-Medicare has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in September 2011.
The peers of Win-Medicare by revenue are Medley Pharmaceuticals Limited, Troikaa Pharmaceuticals Limited, Tenshi Pharmaceuticals Private Limited, Boehringer Ingelheim India Private Limited, Blue Cross Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Ritu Aswal was appointed as Nodal Officer on 25 Nov 2019. Rajive Sawhney ceased to be Director on 06 Sep 2018. Jayesh Modi ceased to be Director Appointed In Casual Vacancy on 30 Jun 2012. Win-Medicare has 13 board changes on record in total.
Win-Medicare has 4 MSME Form 1 returns on record between 2020 and 2021, listing 84 overdue payments to 30 micro and small suppliers. The latest return was filed on 26 Oct 2021.